Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biological properties of human C5a: selected in vitro and in vivo studies.

× No keyword cloud information.

54 in total

1. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors: P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal: J Clin Invest Date: 1977-07 Impact factor: 14.808

2. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors: H N Fernandez; P M Henson; A Otani; T E Hugli
Journal: J Immunol Date: 1978-01 Impact factor: 5.422

3. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

Authors: D E Hammerschmidt; L J Weaver; L D Hudson; P R Craddock; H S Jacob
Journal: Lancet Date: 1980-05-03 Impact factor: 79.321

4. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.

Authors: R O Webster; S R Hong; R B Johnston; P M Henson
Journal: Immunopharmacology Date: 1980-06

5. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.

Authors: H N Fernandez; T E Hugli
Journal: J Immunol Date: 1976-11 Impact factor: 5.422

6. C4a: the third anaphylatoxin of the human complement system.

Authors: J P Gorski; T E Hugli; H J Müller-Eberhard
Journal: Proc Natl Acad Sci U S A Date: 1979-10 Impact factor: 11.205

7. Isolation of three separate anaphylatoxins from complement-activated human serum.

Authors: T E Hugli; C Gerard; M Kawahara; M E Scheetz; R Barton; S Briggs; G Koppel; S Russell
Journal: Mol Cell Biochem Date: 1981-12-04 Impact factor: 3.396

8. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.

Authors: H N Fernandez; T E Hugli
Journal: J Biol Chem Date: 1978-10-10 Impact factor: 5.157

9. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors: D E Chenoweth; T E Hugli
Journal: Proc Natl Acad Sci U S A Date: 1978-08 Impact factor: 11.205

10. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

Authors: E H Vallota; H J Müller-Eberhard
Journal: J Exp Med Date: 1973-05-01 Impact factor: 14.307

7 in total

1. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.

Authors: P J Jose; I K Moss; R N Maini; T J Williams
Journal: Ann Rheum Dis Date: 1990-10 Impact factor: 19.103

Biological properties of human C5a: selected in vitro and in vivo studies.

1. Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

2. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

3. Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value.

4. Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.

5. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.

6. C4a: the third anaphylatoxin of the human complement system.

7. Isolation of three separate anaphylatoxins from complement-activated human serum.

8. Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.

9. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

10. Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator.

1. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase.

2. Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction.

3. Monitoring of immunotherapy with cytokines or monoclonal antibodies.

4. A Gyrolab Assay for the Quantitation of Free Complement Protein C5a in Human Plasma.

5. Chemotactic competence of neutrophils from neonatal calves. Functional comparison with neutrophils from adult cattle.

6. Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils.

7. The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids.